New Research Reveals Psychedelics Impact a Broader Range of Neurons Than Previously Thought

New research from the University of Michigan reveals that psychedelics influence a wider range of neurons, including those lacking serotonin 2A receptors, opening new avenues for brain therapy and neuroplasticity.
Recent findings from the University of Michigan challenge long-held assumptions about how psychedelic substances influence the brain. Traditionally, it was believed that these compounds primarily affected neurons in the frontal cortex that possess serotonin 2A receptors, which are crucial for mood regulation, perception, and cognition. However, a new study published in Molecular Psychiatry demonstrates that psychedelics alter the activity of a much larger population of neurons across various brain regions, including those lacking these receptors.
The research involved analyzing gene expression in neurons throughout the cortex, revealing that many regions such as the retrosplenial cortex—an area vital for memory, spatial orientation, and future self-imagination—are devoid of serotonin 2A receptors. Despite this, psychedelic treatment still induced significant neuroplasticity, including increased synapse formation, suggesting that these non-receptor neurons also respond to psychedelics.
By employing genetic engineering techniques like CRISPR-Cas, the scientists uncovered that psychedelics can promote connectivity in neurons without the traditional receptor. This expands the understanding of their mechanisms, suggesting a more widespread impact on neural networks than previously believed. Such insights could have profound implications for expanding psychedelic therapies beyond mood disorders to conditions like Alzheimer's disease and PTSD, where these brain regions are compromised.
Senior author Omar Ahmed emphasized that fully understanding how psychedelics influence neural circuits is essential for developing effective and safe treatments. While caution is advised due to potential effects on unintended neurons, the findings open promising avenues for brain repair and neuroplasticity in neurodegenerative and psychiatric disorders.
This breakthrough enhances the scientific comprehension of psychedelic action and underscores the need for further research to harness their full therapeutic potential.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Researchers Identify Inflammatory Subtype of Major Depression to Enable Precision Psychiatry
Emory University researchers identify an inflammatory subtype of major depression, paving the way for personalized treatments and improved diagnostic strategies in psychiatry.
Innovative PET Tracer Unveils Synaptic Changes Post-Spinal Cord Injury
A new PET tracer, [18F]SynVesT-1, enables detailed visualization of synapse loss in the spinal cord and brain after injury, offering a promising tool for diagnosis and treatment monitoring of spinal cord injury patients.
Innovative Topical Cream Targeting Dopamine Pathways to Prevent Parasitic Worm Infections
A groundbreaking study reveals that disrupting dopamine pathways in parasitic worms could prevent skin infections. UCLA researchers identify a potential target for innovative topical treatments against parasitic nematodes like Strongyloides stercoralis, offering hope for improved prevention in affected regions.
Automated Smoking Cessation Support for Parents Shows Promise in Reducing Tobacco Use
A new study reveals that automated smoking cessation programs integrated into pediatric care can significantly increase treatment engagement and reduce cigarette use among parents, promoting healthier families.



